Company
Since 1909, Grifols has worked to improve the health and well-being of people around the world.
Read more
Every action we take is motivated by our mission to improve people's lives.
Our unique and remarkable history combines scientific expertise with a desire to serve patients and society.
We develop, produce and market innovative medicines, solutions and services in more than 110 countries.
Innovation
Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.
We apply our growing knowledge of plasma to change healthcare.
Our treatments are enhancing people’s well-being and quality of life.
We’re drawing on a broad scientific base to continue innovating.
Sustainability
Grifols' longstanding commitment to people and the planet entails helping society on all fronts.
2022 Sustainability Report: a detailed overview of our sustainability strategy, actions and progress
Read
Patients drive the work we do every day. We support patients and patient associations.
Learn more
As mindful stewards of the environment we are resolved to fight climate change.
Investors
Here you can read our Q2 2023 financial results
Read results
Please click here to listen to the webcast of our Q2 2023 financial results
Listen to the webcast
The 2022 Integrated and Sustainability Annual Report is now available
Careers
People are at the heart of our business. We are committed to continued investment in training and development.
Media
Latest news about the company and contact information for journalists and communication professionals.
Contact
Second Quarter 2023 Results - Presentation
First Quarter 2023 Results - Presentation
Full Year 2022 Results - Presentation
Third quarter 2022 – Business Update
First Half 2022 Results Presentation
2022 Investor and Analyst Meeting
2022 Investor & Analyst Day Presentation (video)
Transcript video (english)
First quarter 2022 – Business Update
Grifols investment in Biotest (video)
Grifols investment in Biotest (presentation)
2021 Investor and Analyst Meeting
2020 Investor and Analyst Meeting
2019 Investor and Analyst Meeting
2018 Investor and Analyst Meeting
2017 Investor and Analyst Meeting
Executive Report 2017
2016 Investor and Analyst Meeting
Annual report 2016
2015 Investor and Analyst Meeting
Annual report 2015
Investors' presentation
2014 Investor and Analyst Meeting
Annual report 2014
2013 Investor and Analyst Meeting
Annual report 2013
2012 Investor and Analyst Meeting
Annual report 2012
2011 Investor and Analyst Meeting
Annual report 2011
Annual report 2011 – Summary
Annual report 2011 - Interactive link
June 7, 2010 Analyst and investors' presentation regarding acquisition of Talecris Biotherapeutics Holdings Corp
2010 Investors' and Analysts' Meeting
Annual report 2010
Annual report 2010 – Summary
Annual report 2010 – Interactive link
2009 Investor and Analyst Meeting
Annual report 2009
Annual report 2009 - Summary
Annual report 2009 – Interactive link
March 5, 2008 Presentation in Pasadena (USA)
Annual report 2008
